ESMO 2018 Impressions
The medonline team was present at ESMO 2018 to learn about recent developments in Oncology, and to get to know the opinion of renownend experts of the field of how they think these new data will affect the current treatment standards.
More from this topic:
Immuno-Oncology - ESMO 2018
Additive atezolizumab to chemotherapy delays progression in advanced squamous cell carcinoma of the lung
07. 06. 2018